Back
Image credits - IndiaSpend

Is There Any Omicron Medicine In The Indian Market Yet?

With the new variant now being identified on six continents, proposals to vaccinate the entire world’s population are gaining momentum. Vaccine manufacturers have their hands on desks in investigating the potency and efficacy of vaccinations against Omicron. Meanwhile, it is always advisable to keep track of the progress of Omicron meds to combat the new variant.

These antiviral medicines may function as a deterrent to the rising number of cases of Covid-19, which is still dominated by the Delta version.

Some Acclaimed Medicines:

  • Paxlovid: Paxlovid is an antiviral treatment developed by Pfizer to prevent the function of the SARS-CoV-2 protease, an enzyme required for coronavirus replication. According to Pfizer, co-administration with a modest dose of ritonavir slows the protease’s metabolism. It allows the metabolism to stay active in the human body for extended periods at deeper concentrations to help treat the variant. Paxlovid appears to be successful in minimizing the risk of mortality by 89 percent in phase II and III clinical testing.
  • Molnupiravir: Molnupiravir is one of the most effective pills for Omicron. It stops the variant from multiplying by inserting minute imperfections into its genetic code. The said pill has reduced the risk of hospitalization and the rate of mortality as evident by its phase-wise three consecutive trials.
  • Ronapreve: Roche and Regeneron are a mixture of two monoclonal antibodies called casirivimab and imdevimab. The combination aims to stop SARS-CoV-2 from infecting people by attaching to the virus’s spike protein’s key receptor binding domain. The cocktail medicine eventually reduces mutant viruses’ potency to evade treatment. 

Besides, it protects against potential spike versions. Ronapreve seems to sustain neutralization ability against other major developing variants. The antibody combo can be used to treat mild to moderate Omicron infection in adults and children who have been diagnosed with the coronavirus.

The emergence of Omicron medicine is a huge step forward in the pandemic fight. However, it may not have arrived in time to stop the prevailing Omicron wave. The drug supply is still distinctly limited. The positive thing is that scientists now have more answers to those questions than they did when Covid-19 initially appeared two years ago. The majority of the medicines evaluated in large clinical trials were abortive. However, a few of them stand out as prospective, including those that are both inexpensive and acceptable.

Conclusion

The medicinal gamut has a lot to do to alleviate the impact of the impending omicron wave. However, one thing is definite, a large chunk of the populace may get infected like the previous pandemic outbreak. The Omicron variant is extremely contagious. It appears that individuals who have had a record of Covid-19 infection or vaccination are more susceptible to it than to its previous editions.

Source: https://www.indiatvnews.com/health/pfizer-claims-covid-19-medicine-close-to-90-percent-effective-against-hyper-mutated-omicron-variant-750026

https://www.vox.com/future-perfect/22841852/covid-drugs-antibodies-fluvoxamine-molnupiravir-paxlovid

https://www.indiatoday.in/science/story/covid-19-pills-drug-omicron-pfizer-molnupiravir-paxlovid-ronapreve-1889039-2021-12-17

guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x